Skip to main content

Table 1 Participants’ demographic data as characteristics associated with time-to-dropout, with early death as a competing risk

From: Characteristics and patient-reported outcomes associated with dropout in severely affected oncological patients: an exploratory study

  n Time-to-dropout with death as a competing risk Death
SHR (95%CI) HR (95%CI)
Study group
 Intervention 150 1.23 (0.76, 1.99) 1.26 (0.84, 1.88)
 Control 212 1   1  
Age (years) 362 1.01 (0.99, 1.03) 1.02 (1.00, 1.03)
Study site
 Study site 1 119 1    
 Study site 2 98 1.77 (0.94, 3.33) 1.69 (0.99, 2.89)
 Study site 3 145 1.60 (0.87, 2.93) 1.99 (1.22, 3.26)
Sex
 Male 219 1.35 (0.82, 2.24) 0.75 (0.51, 1.11)
 Female 143 1   1  
Family status
 Married 226 1.15 (0.50, 2.67) 1.68 (0.84, 3.38)
 Single 44 1   1  
 Divorced/Widowed 63 2.71 (1.12, 6.56) 0.89 (0.36, 2.20)
Time since diagnosis
  ≤ 6 months 187 1   1  
 7–12 months 49 0.43 (0.17, 1.08) 1.06 (0.58, 1.93)
 13–24 months 46 0.54 (0.22, 1.32) 1.53 (0.87, 2.67)
  > 24 months 80 0.97 (0.54, 1.72) 1.33 (0.81, 2.19)
Diagnosis
 Acute leukemia 69 1   1  
 Aggressive lymphoma 58 1.53 (0.64, 3.65) 0.55 (0.25, 1.23)
 Malignant neoplasm of the bronchus and lungs 62 1.92 (0.84, 4.38) 1.78 (0.97, 3.27)
 Metastatic colorectal cancer/colon carcinoma 78 1.39 (0.60, 3.21) 1.19 (0.64, 2.21)
 Malignant neoplasm of the pancreas 32 1.94 (0.79, 4.77) 2.48 (1.27, 4.85)
 Multiple myeloma and malignant plasma cell neoplasms 24 1.24 (0.40, 3.83) 0.56 (0.19, 1.65)
 Metastasized malignant neoplasm of the breast 9 0.91 (0.11, 7.21) 0.41 (0.05, 3.10)
 Others 30 2.13 (0.79, 5.74) 1.32 (0.58, 3.03)
Education
 Low 29 1.85 (0.90, 3.81) 0.92 (0.39, 2.15)
 Medium 101 1.27 (0.72, 2.25) 1.58 (1.02, 2.45)
 High 206 1   1  
Social support (OSSS-3)
 Poor (3–8) 35 2.10 (1.01, 4.35) 0.83 (0.39, 1.79)
 Moderate (9–11) 158 1.32 (0.74, 2.36) 0.87 (0.56, 1.36)
 Strong (12–14) 139 1   1  
  1. n Number of observation, SHR Sub-hazard ratio, HR Hazard ratio, CI Confidence Interval